Michael Cannon
Director/Board Member at MOLECULIN BIOTECH, INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Walter Klemp | M | 64 | 9 years | |
| Donald Picker | M | 78 | 9 years | |
| Cheng Liu | M | 57 |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 18 years |
| Jacqueline Northcut | F | 62 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 3 years |
| Peter P. Lee | M | - |
Osel, Inc.
 Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | 21 years |
| John Climaco | M | 55 | 7 years | |
| Chau Wai-Yan | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Elizabeth Cermak | F | 66 | 4 years | |
| Robert George | M | 74 | 9 years | |
| Joy Yan | M | 44 | 2 years | |
| Han Zhong Li | M | 56 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 5 years |
| Vivien Chan | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 10 years |
| William S. Solari | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Sandy Chau | M | - |
Osel, Inc.
Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | - |
| Jonathan Foster | M | 60 | 8 years | |
| KT Moortgat | M | - |
Osel, Inc.
Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | - |
| John Paul Waymack | M | 71 | - | |
| Sandra Silberman | M | 69 | 7 years | |
| Robert Lee | M | - |
Osel, Inc.
Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | 31 years |
| Marvin Samson | M | 82 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Bo Feng | M | 53 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Chih Kai Cheng | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Dennis McNamara | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Hale | M | 75 |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 10 years |
| John Sayward | M | 73 |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 5 years |
| David C. Dreyer | M | 67 |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 7 years |
| Paul Laikind | M | 68 |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 13 years |
| Martha L. Hough | F | 70 |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 11 years |
| John Roberts | M | 79 |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 2 years |
| Michael D. Casey | M | 78 |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 2 years |
| Louis Ploth | M | 70 | 1 years | |
| Barbara H. Deptula | F | 69 |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 1 years |
| Patricia L. Novak | M | - |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 6 years |
| Waldemar Priebe | M | - | - | |
| Robert Shepard | M | 71 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Cannon
- Personal Network
